The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of mutational status with metastatic pattern, race, ethnicity, and overall survival (OS) in leiomyosarcoma (LMS).
 
Hayes Pearce
No Relationships to Disclose
 
Chang Yu-Cherng
No Relationships to Disclose
 
Brandon Edward Rose
No Relationships to Disclose
 
Emily E. Jonczak
No Relationships to Disclose
 
Julie Grossman
No Relationships to Disclose
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Marilyn Huang
Consulting or Advisory Role - Agenus; Aptitude Health; Aspira Women's Health; Clovis Oncology; Cooper Surgical; Curio Science; Eisai; Elsevier; FLASCO; Immunogen; IntegrityCE; MJH Healthcare Holdings, LLC; Natera; Seagen; Seagen; Swedish Cancer Center; Tesaro; touchIME; VBL Therapeutics; Voluntis
Research Funding - Merck (Inst)
 
Jonathan C. Trent
Consulting or Advisory Role - AADi; Agios; Bayer; Blueprint Medicines; Boehringer Ingelheim; C4 Therapeutics; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; Foghorn Therapeutics; SERVIER
 
Francesco Alessandrino
Research Funding - Ascelia